Danaher Lifts 2026 Adjusted EPS Outlook To $8.57-$8.62 As Core Growth Ex-Respiratory Hits 5.5%
Third-quarter net earnings rose 34.5% to $1.2 billion, helped by a $263 million net discrete tax benefit.
Danaher raised its 2026 adjusted earnings-per-share guidance to $8.57 to $8.62, from $8.45 to $8.60, in its third-quarter earnings release, furnished with an 8-K that EDGAR accepted Tuesday evening. The release itself is dated October 21.
What the quarter showed
Net earnings were $1.2 billion, or $1.71 per diluted share, up 34.5% from a year earlier. Revenue rose 8.5% to $6.6 billion.
Adjusted earnings per share grew 11.5% to $2.11. Core revenue, which strips out currency swings and acquisitions, rose 3.0%, or 5.5% excluding respiratory testing.
Operating cash flow was $1.9 billion and free cash flow, which subtracts capital spending, was $1.6 billion.
CEO Julie Sawyer Montgomery said Danaher delivered "better-than-expected third quarter revenue, earnings and cash flow," and cited "improving trends we saw across our end markets."
The tax item and the segments
Reported earnings got a lift from $263 million of net discrete tax benefits, tied mainly to releasing reserves for uncertain tax positions after audit settlements. The release's adjusted EPS reconciliation removes a $0.37 per-share discrete tax adjustment.
By segment, core sales grew 5.0% in Biotechnology, 4.5% in Life Sciences and 0.5% in Diagnostics. Excluding respiratory testing, Diagnostics core growth was 6.5%.
The company also began excluding tariff refunds passed to customers from core growth this quarter.
Fourth-quarter outlook and the call
For the fourth quarter, Danaher expects core revenue excluding respiratory testing to grow 4.0% to 5.0%. It sees respiratory testing as a headwind of about 150 basis points, or 1.5 percentage points, leaving core growth of about 3.0%.
The company also guides to an adjusted operating margin of about 29.5% for the quarter. Management discusses the results and key assumptions on an investor call starting at 8:00 a.m. ET Wednesday.
The call, with its slide presentation, is where management is due to lay out the assumptions behind the raised range.
Sources
- 8-K Filing — DANAHER CORP /DE/ (DHR) — SEC EDGAR
- Exhibit dhr-20261021xex991.htm — DANAHER CORP /DE/ 8-K exhibit — SEC EDGAR